Curing Parkinson’s needs world-class collaborative science involving researchers, clinicians, the pharmaceutical industry and, most importantly, people who are living with Parkinson’s. This collaboration is at the heart of our research programme.

Our leadership and funding enables the world’s leading neuroscientists and neurologists to prioritise, together, the next generation of drugs for clinical trial. We’re acting with urgency, for people currently living with Parkinson’s, with a focus on research which has potential to translate into the clinic within five years